Invesco Pharmaceuticals ETF
PJP
105 hedge funds and large institutions have $426M invested in Invesco Pharmaceuticals ETF in 2015 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 29 reducing their positions, and 8 closing their positions.
113% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 8
63% more call options, than puts
Call options by funds: $1.58M | Put options by funds: $970K
31% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 29
24% more capital invested
Capital invested by funds: $343M → $426M (+$83.1M)
8% more funds holding
Funds holding: 97 → 105 (+8)
1.25% less ownership
Funds ownership: 23.24% → 21.99% (-1.3%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
+$5.7M |
| 2 |
PAM
Peak Asset Management
Louisville,
Colorado
|
+$5.34M |
| 3 |
LPL Financial
San Diego,
California
|
+$5.22M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$4.35M |
| 5 |
NFC
Northeast Financial Consultants
Westport,
Connecticut
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFG
Pacific Financial Group
Bellevue,
Washington
|
-$13.5M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.58M |
| 3 |
CK
Carnick & Kubik
Colorado Springs,
Colorado
|
-$1.3M |
| 4 |
AIG
American International Group
New York
|
-$1.19M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$919K |
PJP Hedge Fund Activity: Q1 2015 in Review
105 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2015, worth a combined $426M — up 24% from $343M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new PJP positions and 8 closed out — a net gain of 9 holders — while 38 added to existing stakes and 29 trimmed.
The largest buyer was MSI Financial Services, opening a new position worth an estimated $5.7M. The largest seller was Pacific Financial Group, cutting an estimated $13.5M.
- 105 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2015, up from 97 in Q4 2014.
- Funds reported $426M of Invesco Pharmaceuticals ETF stock for Q1 2015, up 24% quarter-over-quarter.
- 17 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2015 and 8 closed out, a net change of +9 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2015 was MSI Financial Services, an estimated $5.7M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2015 was Pacific Financial Group, an estimated $13.5M sold.
Based on aggregated 13F filings for Q1 2015.